Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Ogmend® Implant Enhancement System

K-Number: K223075 · 2023-02-27

Decision Date2023-02-27
Product CodeQVI
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Ogmend® Implant Enhancement System is a medical device manufactured by Woven Orthopedic Technologies. It received FDA 510(k) clearance on 2023-02-27 under approval number K223075. The device is classified under product code QVI. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Ogmend® Implant Enhancement System?

Ogmend® Implant Enhancement System is a medical device that received FDA 510(k) clearance on 2023-02-27. It is manufactured by Woven Orthopedic Technologies. The 510(k) number is K223075.

When was Ogmend® Implant Enhancement System approved by the FDA?

Ogmend® Implant Enhancement System received FDA 510(k) clearance on 2023-02-27, under approval number K223075.

What company makes Ogmend® Implant Enhancement System?

Ogmend® Implant Enhancement System is manufactured by Woven Orthopedic Technologies.

What is the FDA product code for Ogmend® Implant Enhancement System?

The FDA product code for Ogmend® Implant Enhancement System is QVI.

Related Clinical Trials

Related PubMed Literature

Other Devices by Woven Orthopedic Technologies

Related Devices (Code: QVI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.